Antidepressant drugs as a tool to investigate CNS--anterior pituitary interactions
Cocchi, D.; Locatelli, V.; Cella, S.; Peñalva, A.; Müller, E.E.
Advances in Biochemical Psychopharmacology 32: 317-328
1982
ISSN/ISBN: 0065-2229 PMID: 6124091 Document Number: 182775
Document emailed within 1 workday
Related Documents
Gmeiner, W.H. 1998: NMR spectroscopy as a tool to investigate the structural basis of anticancer drugs Current Medicinal Chemistry 5(2): 115-135Eldefrawi, A.T.; Miller, E.R.; Murphy, D.L.; Eldefrawi, M.E. 1982: 3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs Molecular Pharmacology 22(1): 72-81
Nagy, I.; Kurcz, M.; Halmy, L.; Mosonyi, L.; Baranyai, P.; Kiss, C. 1970: Effect of stress, drugs and hypothalamic extract on anterior pituitary somatotropin content in the rat Acta Physiologica Academiae Scientiarum Hungaricae 38(4): 357-370
Magnoni, M.S.; Govoni, S.; Cappellato, G.; Trabucchi, M. 1986: Study of brain capillary neuronal regulation as a tool to investigate cerebral asymmetries Functional Neurology 1(2): 105-111
Casu, A.; Averame, M.M.; Piemontese, R. 1988: Monensin and bile protein secretion. A tool to investigate hepatocyte intracellular vesicular polarity Italian Journal of Biochemistry 37(3): 139-147
Neubert, R.; Fritsch, B.; Dongowski, G. 1995: Interactions between food components and drugs. Part 3. Interactions between pectin and propranolol Die Pharmazie 50(6): 414-416
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Gaillard, J.M.; de St Hilaire-Kafi, S. 1985: Sleep, depression and the effects of antidepressant drugs Acta Psychiatrica Belgica 85(5): 561-567
Hickie, I.B. 2001: Choosing antidepressant drugs in general practice Australian Family Physician 30(7): 663-667
Grzesiak, M.; Beszłej, J.A.; Szewczuk-Bogusławska, M. 2003: Therapeutic monitoring of tricyclic antidepressant drugs Psychiatria Polska 37(5): 825-837
Maj, J. 1987: Pharmacological profile and mechanism of action of antidepressant drugs Acta Physiologica Polonica 38(4): 289-301
Benesová, O. 1970: Neurophysiological and biochemical aspects in the action of antidepressant drugs Activitas Nervosa Superior 12(3): 226-234
2006: Antidepressant drugs increase suicide risk in children Journal of Family Practice 55(6): 488
Wynn, R.L. 2010: Antidepressant drugs: new reports on adverse effects and efficacy General Dentistry 58(6): 474-477
Vetulani, J. 1989: The development of understanding of the mechanism of action of antidepressant drugs Activitas Nervosa Superior 31(1): 24-25
Tsali, L.; Bristianou, M.; Valachis, A.; Mauri, D.; Barotsis, N.; Bellou, E. 2009: Antidepressant drugs in cancer patients: the case of escitalopram Journal of Supportive Oncology 7(4): 119
Gillette, R.D.; Oxman, T.E. 1983: Tricyclic antidepressant drugs in the ambulatory treatment of depression Journal of Family Practice 17(2): 342-344
Solbach, H.G.; Kley, H.K.; Herrmann, J.; Wiegelmann, W.; Krüskemper, H.L. 1980: Anterior pituitary insufficiency Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 25-36
Kumar, S.; Kulkarni, S.K. 1996: Influence of antidepressant drugs on learning and memory paradigms in mice Indian Journal of Experimental Biology 34(5): 431-435
Rouillon, F.; Blachier, C.; Dreyfus, J.P.; Bouhassira, M.; Allicar, M.P. 1996: Pharmaco-epidemiologic study of the use of antidepressant drugs in the general population L'Encephale 22(Special Issue 1): 39-48